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The two cardinal symptoms of congestive heart failure are
shortness of breath and fatigue. If not present at rest, these
symptoms are precipitated by exercise
. It is commonly
accepted that the dyspnea of congestive heart failure is
caused by pulmonary congestion (1). An increase in pulmo-
nary cap'lary pressure leads to interstitial edema, and the
stimula,'.on of afferent nerve endings increases ventilatory
drive . The report by Reddy et al . (2) in this issue of the
Journal suggests that breathlessness in congestive heart
failure may be more related to factors that cause fatigue
during exercise than to changes in pulmonary capillary
pressure.
Ventilator responses to exercise in congestive heart fall .
we . Reddy et al. (2) examined ventilatory and metabolic
responses of patients with congestive heart failure during
light isometric handgrip exercise (25% of a maximal contrac-
tion) held for 6 min
. Whereas normal subjects increased
cardiac output and stroke volume, patients with congestive
heart failure did am . This was presumably due to the
increased afterload from excessive vasoconstriction . Pa-
tients with congestive heart failure increased their mixed
venous lactate and the lactate concentration of venous blood
from their exercising arm, not only during exercise but also
during early recovery
. This suggested to the authors that
oxygen delivery
to the exercising muscle was inadequate to
support oxidative metabolism
. Minute ventilation for the
patients was greater than normal, a difference that persisted
into the early recovery period when carbon dioxide produc-
tion was significantly increased, The authors suggested that
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the increased ventilatory drive resulted from either chemo-
receptor stimulation from the increased carbon dioxide
production due to buffering of lactic acid with bicarbonate or
from stimulation of somatic afferent nerve fibers in exer-
cising muscle by products of metabolism, The work of
breathing increased sufficiently to increase systemic oxy-
gen consumption and lead to the subjective sensation of
"breathlessness ."
Metabolic respoma to exercise in heart k1m. During
dynamic exercise ; patients with beam failure generally stop
because of fatigue (3). In an animal model of moderate
compensated congestive heart failure (4), this occurs when
there is depletion of glycogen in skeletal muscle and liver, a
process that may be more rapid in heart failure
. With use of
nuclear magnetic resonance spectroscopy to evaluate sub-
strate utilization during exercise, it has been demonstrated
(5) that there is more rapid depletion of creative phosphate
and a decrease in pH in exercising muscle in heart failure .
Two possibilities may account for this response . One possi-
bility is that flow to working muscle is hindered (6,7),
causing an imbalance between energy requirements and
oxygen/substrate delivery (blood flow abnormality) . Another
possibility is that flow may be adequate but there may be an
imbalance between energy requirements and oxygeWsub
strafe utilization (metabolic abnormality) (8,9) . This latter
possibility closely resembles a
situation
of exercise decon-
ditioning in which skeletal muscle oxidative enzymes may be
significantly reduced (10) . Thus, the metabolic pattern of
exercising skeletal muscle in heart failure may be related to
the voluntary selection of inactivity by the patient or inac-
tivity prescribed by the physician .
Blood
flow abnormality daring exercbe In heart fame
.
Recent data also suggest that pmt of the "detrained" state of
congestive heart failure is related to blood flow abnormalities
(11), especially an inadequate blood flow delivery to exer-
cising muscle in heart failure, which hag been known for
some time (6) . This is related to a number of factors
including an inadequate pressor response to exercise and a
limited capacity of the vasculature of skeletal muscle to
dilate normally to a metabolic stimulus, This inability to
dilate normally is not caused by increased sympathetic
nervous system activity. In fact, alpha receptor stimulation
in an exercising vascular bed can reduce blood Bow but
redistributes flow from inactive to active exercising skeletal
muscle fibers, thereby allowing the skeletal muscle to main-
tain a normal oxygen consumption during submaximal exer-
cise (12). Conversely, a restriction of blood flow at the
arterial level seems to limit oxidative metabolism in exercis-
ing muscle (12) . This could be caused by an increased
vascular sodium or water content, an increased tissue pres
.
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sure limiting blood flow by extravascular compression or a
deconditioning response (7) .
Although exercise conditioning has been thought to relate
to changes in skeletal muscle oxidative metabolism brought
about by training programs involving repeated sustained
episodes of dynamic exercise, it has been demonstrated
more recently that the blood vessels can participate in the
conditioning response as well (I3). More importantly, decon-
ditioning as it occurs in heart failure has been implicated as
a major factor in limiting maximal blood flow delivery (11) . It
has been suggested that chronic high flow states can result in
endothelial
changes that lead to a facilitated release of
endothelially derived relaxing factor (14). The converse has
also been shown in heart failure (15). The level at which this
has functional implications for patients is probably the small
arteries, which can contribute significantly to vascular resis-
tance, especially during high flow states. The ability of small
arteries to change caliber is probably an important compo-
nent determining linkage of cardiac function with arteriolar
tone.
Role of therapy in Improving exercise tolerance . Perhaps
the importance of the question posed in the title of this
article (2) lies in its relevance to the mechanism by which
successful therapy for heart failure improves exercise toler-
ance (7,11)
.
Therefore, the more important question is why
does vasodilator therapy for heart failure lead to an im-
proved exercise tolerance (7)? Therapeutic regimens with
diuretics, angiotensin-converting enzyme inhibitors and ni-
trates have in common the capacity to lower pulmonary
capillary wedge pressure . Because a short-term reduction in
filling pressure with vasodilator therapy neither increases
nutritional flow to exercising skeletal muscle nor leads to an
immediate improvement in exercise tolerance, further cre-
dence is given to the hypothesis that dyspnea is not the
major limiting factor for exercise performance in heart
failure (3). However, the long-term relief of dyspnea at rest
may be the important feature common to therapy with these
three agents. Nitrates and converting enzyme inhibitors
reduce filling pressure by dilating veins and improving renal
blood flow, and diuretics and converting enzyme inhibitors
lead to diuresis and natriuresis (7) . With the long-term relief
of dyspnea at rest, the patient's sense of well-being would be
increased and greater activity would be attempted . Blood
flow to skeletal muscle would be improved somewhat by the
natriuresis alone (16) and therefore some increment in exer-
cise capacity could be sustained. With exercise, a condition-
ing-induced increase in vasodilator capacity and in skeletal
muscle oxidative capacity would result (17). This would
increase aerobic capacity further and would reinforce the
cycle by allowing the patient to do more
.
The slow improvement in exercise capacity after vasodi-
lator and diuretic therapy is consistent with the slow devel-
opment of conditioning-induced changes in vasodilator ca-
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pacity and skeletal muscle oxidative enzymes seen with an
exercise conditioning program . Once these have improved,
the return of the characteristic congestive heart failure
abnormalities with discontinuation of drug therapy should
also occur slowly . Therefore, during studies of these abnor-
malities in a group of patients with heart failure who are well
compensated with drug therapy, the discontinuation of med-
ications for 24 to 4t h would not likely cause those abnor-
malities to reappear, whereas abnormalities such as changes
in ventricular filling pressure, vascular resistance at rest and
indexes of sympathetic tone might become abnormal more
quickly .
In summary, the study by Reddy et al. (2) adds signifi-
cantly to our understanding of the pathophysiology of heart
failure in that it helps us place into perspective the role of
breathlessness and fatigue as symptoms of heart failure and
the fact that they are interrelated and that they may play
different roles in the pathophysiology of the heart failure
syndrome when the subject is at rest, exercising and recov-
ering from exercise .
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